Biotech

All Articles

Novartis pens $150M in advance bispecifics manage Dren Bio

.Novartis has actually had some rotten luck along with bispecific antibodies previously, yet evaluat...

AstraZeneca vegetations an EGFR plant along with Pinetree bargain worth $45M

.Pinetree Rehabs are going to assist AstraZeneca vegetation some plants in its own pipeline with a b...

GRO rounds up $60M series B to take gout arthritis therapy into medical clinic

.GRO Biosciences has actually ended the week with an extra $60.3 thousand in the bank, which the pro...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava sheds chief executive officer

.Welcome to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings as w...